UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)16-19
Number of pages4
JournalThrombosis Research
Volume197
DOIs
Publication statusPublished - Jan 2021

Keywords

  • Factor Xa Inhibitors
  • Obesity
  • Rivaroxaban
  • Venous thromboembolism

Cite this